News brief­ing: Zio­pharm dra­ma con­tin­ues with new let­ter from ac­tivist group; Al­ny­lam, Cen­to­gene join forces on AT­TRv screen­ing pro­gram

As Fri­day’s dead­line to sub­mit writ­ten con­sent ap­proach­es, Wa­ter­Mill As­set Man­age­ment Corp is con­tin­u­ing to put the pres­sure on Zio­pharm On­col­o­gy in its ac­tivist at­tack …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER